BACKGROUND: Tumor necrosis factor-alpha (TNFalpha) is an important mediator of inflammatory and autoimmune diseases. Analysis of its pathophysiologic roles has been difficult because low concentrations of TNFalpha, including those in healthy controls, cannot be measured by existing methods. METHODS: We developed a sensitive immuno-PCR assay for the detection of TNFalpha in human serum. The DNA label was generated by PCR amplification using biotinylated primer and was bound with streptavidin to the biotinylated third antibody. TNFalpha sandwiched by antibodies was detected by amplification of the DNA label using PCR. RESULTS: The limit of detection of the assay was 0. 001 ng/L, an approximately 5 x 10(4)-fold improvement compared with a conventional ELISA. The mean serum TNFalpha concentration (+/- SD) in healthy donors was 0.021 +/- 0.044 ng/L in men (n = 29) and 0.033 +/- 0.065 ng/L in women (n = 25). CONCLUSION: This method may be useful for analyzing the significance of TNFalpha concentration in various diseases. Copyright 1999 American Association for Clinical Chemistry.
BACKGROUND:Tumor necrosis factor-alpha (TNFalpha) is an important mediator of inflammatory and autoimmune diseases. Analysis of its pathophysiologic roles has been difficult because low concentrations of TNFalpha, including those in healthy controls, cannot be measured by existing methods. METHODS: We developed a sensitive immuno-PCR assay for the detection of TNFalpha in human serum. The DNA label was generated by PCR amplification using biotinylated primer and was bound with streptavidin to the biotinylated third antibody. TNFalpha sandwiched by antibodies was detected by amplification of the DNA label using PCR. RESULTS: The limit of detection of the assay was 0. 001 ng/L, an approximately 5 x 10(4)-fold improvement compared with a conventional ELISA. The mean serum TNFalpha concentration (+/- SD) in healthy donors was 0.021 +/- 0.044 ng/L in men (n = 29) and 0.033 +/- 0.065 ng/L in women (n = 25). CONCLUSION: This method may be useful for analyzing the significance of TNFalpha concentration in various diseases. Copyright 1999 American Association for Clinical Chemistry.
Authors: Bernard S Munge; Jacqueline Fisher; Lines N Millord; Colleen E Krause; Richard S Dowd; James F Rusling Journal: Analyst Date: 2010-03-31 Impact factor: 4.616
Authors: Ming Jun Deng; Xi Zhi Xiao; Yan Ming Zhang; Xin Hai Wu; Lai Hua Zhu; Xue Qian Xin; Dong Lai Wu Journal: Mol Biol Rep Date: 2010-09-22 Impact factor: 2.316
Authors: Dan Du; Zhexiang Zou; Yongsoon Shin; Jun Wang; Hong Wu; Mark H Engelhard; Jun Liu; Ilhan A Aksay; Yuehe Lin Journal: Anal Chem Date: 2010-04-01 Impact factor: 6.986
Authors: K Sudhakara Prasad; Xiyue Cao; Ning Gao; Qijie Jin; Sharma T Sanjay; Gilberto Henao-Pabon; XiuJun Li Journal: Sens Actuators B Chem Date: 2019-12-02 Impact factor: 7.460
Authors: James Flanigon; Masood Kamali-Moghaddam; Ian Burbulis; Carla Annink; Martin Steffen; Paul Oeth; Roger Brent; Dirk van den Boom; Ulf Landegren; Charles Cantor Journal: N Biotechnol Date: 2012-11-28 Impact factor: 5.079